Wuhan General Group (China) WUHN Stock
Wuhan General Group (China) Price Chart
Wuhan General Group (China) WUHN Financial and Trading Overview
| Wuhan General Group (China) stock price | 0.0000 USD |
| Previous Close | 0.0004 USD |
| Open | 0.0004 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0004 - 0.0004 USD |
| 52 Week Range | 0.0004 - 0.3 USD |
| Volume | 5K USD |
| Avg. Volume | 54.33K USD |
| Market Cap | 3.05M USD |
| Beta (5Y Monthly) | 1.962676 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
WUHN Valuation Measures
| Enterprise Value | 131.29M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.037988447 |
| Price/Book (mrq) | 0.00017094017 |
| Enterprise Value/Revenue | 1.633 |
| Enterprise Value/EBITDA | 345.564 |
Trading Information
Wuhan General Group (China) Stock Price History
| Beta (5Y Monthly) | 1.962676 |
| 52-Week Change | -99.86% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.3 USD |
| 52 Week Low | 0.0004 USD |
| 50-Day Moving Average | 0.0097356 USD |
| 200-Day Moving Average | 0.03 USD |
WUHN Share Statistics
| Avg. Volume (3 month) | 54.33K USD |
| Avg. Daily Volume (10-Days) | 2K USD |
| Shares Outstanding | 33.93M |
| Float | 11.8M |
| Short Ratio | 0.15 |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.0040% |
| Shares Short | 12.62K |
| Short % of Float | 0.10% |
| Short % of Shares Outstanding | 0.040% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:2000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2012 |
| Most Recent Quarter (mrq) | December 31, 2012 |
| Next Fiscal Year End | December 31, 2013 |
Profitability
| Profit Margin | -13.17% |
| Operating Margin (ttm) | -2.76% |
| Gross Margin | 18.09% |
| EBITDA Margin | 0.47% |
Management Effectiveness
| Return on Assets (ttm) | -0.49% |
| Return on Equity (ttm) | -8.78% |
Income Statement
| Revenue (ttm) | 80.38M USD |
| Revenue Per Share (ttm) | 2.47 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 14.54M USD |
| EBITDA | 379.92K USD |
| Net Income Avi to Common (ttm) | -10605073 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 18.79M USD |
| Total Cash Per Share (mrq) | 0.55 USD |
| Total Debt (mrq) | 118.8M USD |
| Total Debt/Equity (mrq) | 110.68 USD |
| Current Ratio (mrq) | 1.101 |
| Book Value Per Share (mrq) | 2.34 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -21859288 USD |
| Levered Free Cash Flow (ttm) | -37940804 USD |
Profile of Wuhan General Group (China)
| Country | United States |
| State | QC |
| City | Pointe-Claire |
| Address | 6500 Transcanada hwy |
| ZIP | H9R 0A5 |
| Phone | 514-928-7368 |
| Website | https://wuhn.org |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 700 |
Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.
Q&A For Wuhan General Group (China) Stock
What is a current WUHN stock price?
Wuhan General Group (China) WUHN stock price today per share is 0.0000 USD.
How to purchase Wuhan General Group (China) stock?
You can buy WUHN shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Wuhan General Group (China)?
The stock symbol or ticker of Wuhan General Group (China) is WUHN.
Which industry does the Wuhan General Group (China) company belong to?
The Wuhan General Group (China) industry is Drug Manufacturers-Specialty & Generic.
How many shares does Wuhan General Group (China) have in circulation?
The max supply of Wuhan General Group (China) shares is 0.
What is Wuhan General Group (China) Price to Earnings Ratio (PE Ratio)?
Wuhan General Group (China) PE Ratio is now.
What was Wuhan General Group (China) earnings per share over the trailing 12 months (TTM)?
Wuhan General Group (China) EPS is 0 USD over the trailing 12 months.
Which sector does the Wuhan General Group (China) company belong to?
The Wuhan General Group (China) sector is Healthcare.